Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
36.71
-0.44 (-1.18%)
At close: Nov 17, 2026, 4:00 PM EST
36.07
-0.64 (-1.74%)
After-hours: Nov 17, 2026, 7:40 PM EST
Progyny Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Progyny stock has a consensus rating of "Strong Buy" and an average price target of $37.75. The average 1-year stock price forecast is 2.83% higher than the current stock price, while the lowest is $35 (-4.66%) and the highest is $42 (+14.41%).
Price Target: $37.75 (+2.83%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Progyny stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 9 | 9 | 9 | 9 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Reiterates $36 → $42 | Buy | Reiterates | $36 → $42 | +14.41% | Nov 16, 2026 |
| Barclays | Barclays | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +0.79% | Nov 11, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates $30 → $35 | Hold | Reiterates | $30 → $35 | -4.66% | Nov 9, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $37 → $38 | Buy | Reiterates | $37 → $38 | +3.51% | Nov 5, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $31 → $35 | Buy | Maintains | $31 → $35 | -4.66% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
1.38B
from 1.29B
Increased by 6.86%
Revenue Next Year
1.54B
from 1.38B
Increased by 11.88%
EPS This Year
2.11
from 1.89
Increased by 11.82%
EPS Next Year
2.40
from 2.11
Increased by 13.63%
EPS and Forward PE are based on non-GAAP adjusted numbers.